Form 4: Criteo CLO Sells Shares Under 10b5-1 Plan

Criteo's Chief Legal Officer, Ryan Damon, disposed of 6,444 ordinary shares at a reported price of $22.14 per share under a Rule 10b5-1 plan.

Summary

• Ryan Damon, Chief Legal Officer of Criteo S.A. (CRTO), reported a disposition of 6,444 ordinary shares.
• The transaction occurred on November 13, 2025, and was filed on November 14, 2025.
• The shares were disposed of at a reported price of $22.14 per share.
• This transaction was made pursuant to a Rule 10b5-1(c) plan, indicating a pre-planned sale.
• Following the transaction, Ryan Damon beneficially owns 120,902 ordinary shares directly.
• The filing contains an inconsistency: while the transaction is a disposition ('S') at $22.14, footnote 2 states this price is a 'weighted average purchase price' for shares bought between $24.06 and $26.12.
• The transaction date of November 13, 2025, is in the future relative to the filing date of November 14, 2025, which is unusual for a Form 4 reporting past transactions.

Sentiment

Score: 5

Explanation: A routine insider transaction (sale) under a 10b5-1 plan. The sale itself is a minor negative, but the pre-planned nature mitigates concerns. The contradictory explanation regarding the sale price and the future transaction date are minor clarity issues within the filing itself.

Positives

• The transaction was executed under a Rule 10b5-1(c) plan, which indicates a pre-planned sale and helps mitigate concerns about opportunistic insider trading.

Negatives

• Insider selling by a Chief Legal Officer, even under a 10b5-1 plan, can sometimes be perceived negatively by the market.
• The filing contains a significant internal inconsistency: the transaction is reported as a disposition ('S') at $22.14 per share, but footnote 2 states that the reported price is a 'weighted average purchase price' ranging from $24.06 to $26.12, which contradicts the nature of a disposition.
• The transaction date of November 13, 2025, is in the future relative to the filing date of November 14, 2025, which is highly unusual for a Form 4 that reports past transactions.

Future Outlook

This filing, a Form 4, reports a past insider transaction and does not provide any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

Insider transactions, such as the sale reported in this Form 4, are routine disclosures for publicly traded companies. The use of a 10b5-1 plan is a common practice among executives to manage their equity holdings in compliance with insider trading regulations.

Corporate Governance

Stakeholder Impact

• Shareholders: A routine insider sale, while generally not a strong signal, can sometimes be viewed with slight caution, though the 10b5-1 plan mitigates concerns about opportunistic timing.

Key Dates

Recommendation

This Form 4 reports a routine, pre-planned sale of shares by a company executive under a Rule 10b5-1 plan. While insider selling can sometimes be a negative signal, the pre-planned nature mitigates concerns about opportunistic timing. The transaction itself is not significant enough to warrant a change in investment recommendation based solely on this filing. The inconsistencies in the filing regarding the transaction date and price explanation are noted but do not fundamentally alter the nature of this routine disclosure.

Keywords

Criteo, CRTO, Form 4, Insider Transaction, Share Sale, Ryan Damon, 10b5-1 Plan, Chief Legal Officer